Latest Remuneration And Governance News

Axel REE has appointed Dr Patience Mpofu as Managing Director, positioning the company to advance its rare earths portfolio from exploration into commercial development with planned in-situ recovery trials.

Ryman Healthcare nearly doubles operating profitability and generates positive free cash flow for the first time in over a decade, while shifting strategy toward sustainable growth and targeting dividend returns by FY28.

Amplia Therapeutics reported encouraging mature data from its ACCENT pancreatic cancer trial showing improved survival and response rates with narmafotinib. The company raised $27.5 million to fund development and manufacturing scale-up, while discontinuing a parallel trial due to chemotherapy toxicity.

Macquarie Bank Limited has posted a robust FY2026 result, with net profit attributable to ordinary equity holders soaring 74% to AUD 6.011 billion, underpinned by strong performances in its Banking and Financial Services and Commodities and Global Markets divisions.

Xstate Resources has issued a cleansing prospectus to remove trading restrictions on recently placed shares and associated options, following a $1.69 million capital raise priced at 3.3 cents per share. The offer includes free attaching options to placement participants, brokers, and consultants, subject to shareholder approval.

DroneShield Limited has appointed Angus Bean as its new CEO and Hamish McLennan as Chairman, following the departures of Oleg Vornik and Peter James. The company also reported record cash receipts of $77 million in the first quarter of 2026, reflecting strong growth momentum.

Brisbane Broncos Limited has reported a robust 2025 financial year, with profit before tax soaring 35% to $11.34 million, buoyed by premiership wins in both the NRL and NRLW competitions. The club also declared a special dividend, reflecting its strong commercial and community momentum.

Regal Partners Limited reported a near doubling of net profit after tax to $130.5 million for 2025, alongside a 16% rise in funds under management to $20.9 billion. The company declared a fully franked 15 cent dividend and announced a $75 million on-market share buy-back program.

Stanmore Resources Limited posted a net loss of US$47.2 million for 2025, impacted by a 21% revenue decline due to lower coal prices despite record production and cost efficiencies. The company declared a fully franked final dividend of US 8.9 cents per share.

Iluka Resources posted a net loss of $288 million in 2025 amid subdued mineral sands demand but progressed key projects including the Balranald mine commissioning and Eneabba rare earths refinery construction.

Genetic Signatures has appointed Anne Lockwood as interim Managing Director, bringing extensive financial expertise to guide the company through a critical transition period.

InVert Graphite has completed its maiden drilling program at the Kumba deposit in Tanzania, revealing wide zones of high-grade graphite near surface and positioning the Morogoro Project for further advancement.